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ABSTRACT
PURPOSE: To comparatively study the efficacy and maternal and fetal side-effects of two doses of bupivacaine associated 
with morphine and clonidine, administered by the subarachnoid route for cesarean section.
 METHODS: The study included 66 pregnant women at term, distributed into two groups. GI:  bupivacaine 8.0 mg (1.6mL) 
+ clonidine 75µg (0.5mL) + morphine 100µg (1.0mL) and GII: bupivacaine 10mg (2.0mL) + clonidine 75µg (0.5mL) + 
morphine 100µg (1.0mL). The following parameters were assessed: onset and maximum level of sensory block; quality of 
intraoperative and postoperative analgesia; degree and duration of motor block; maternal repercussions and Apgar score. 
RESULTS: The onset of sensory block, quality of intraoperative analgesia and total duration of analgesia were similar in 
both groups;  maximum extent of sensory block predominated in T4; maximum degree of motor block (Bromage 3); time 
motor block regression was significantly longer in GII; Hemodynamic, respiratory repercussions, adverse maternal effects 
and Apgar scores were similar between groups. In both groups, there was a predominance of drowsy or sleeping patients.
CONCLUSION: The addition of morphine and clonidine to low doses of hyperbaric bupivacaine produced 
adequate anesthesia for cesarean section and good postoperative analgesia, without any maternal and fetal 
repercussions.
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Introduction
Hyperbaric bupivacaine in spinal anesthesia is commonly 
used for the performance of cesarean delivery. Its association with 
adjuvant drugs not only improves the quality of intraoperative 
analgesia and prolongs postoperative analgesia, but allows use 
of smaller doses, decreasing the risk of maternal hypotension and 
damage to the fetus1-5. Subarachnoid opioids have been used for 
acute and chronic pain control2,3. Clonidine, a partial agonist of 
a2-adrenergic receptors, interacts with local anesthetics in the 
neural axis. The analgesic effect of the drug is quite evident, due 
to its action on spinal and supraspinal a2-adrenergic receptors 
(CNS), including activation of a2 postsynaptic receptors from 
noradrenergic descending pathways of cholinergic neurons and 
the release of nitric oxide and substances such as encephalin5-7. 
In cesarean section, the morphine dose recommended to produce 
satisfactory intra- and postoperative analgesia is 100 to 200µg, 
while the recommended for clonidine doses range from 15 to 
150µg2,6-8.
The aim of this study was to comparatively evaluate 
the effectiveness of different doses of hyperbaric bupivacaine 
associated with morphine and clonidine in the quality of block 
and maternal and neonatal repercussions, in pregnant women 
undergoing cesarean section under spinal anesthesia.
Methods
The study was performed after obtaining approval from 
the Medical Research Ethics Committee of the institution (CEP-
number 325/2011) and informed consent signature. This was 
a double-blind, randomized clinical trial, which consecutively 
included pregnant women at term, physical status ASA 1 and 
2, undergoing elective cesarean section and receiving spinal 
anesthesia. Exclusion criteria were: contraindications to spinal 
block, prematurity, multiple pregnancy, preeclampsia, history of 
hypersensitivity to drugs used, previous administration of opioids 
and/or other CNS depressants, Body Mass Index (BMI) > 40.
Based on the results of Braga et al.9, considering that the 
dependent variable time for motor block regression was 255.75 
± 71.47 minutes, when a combination of bupivacaine 10mg + 
clonidine 75µg + morphine 100µg was used in the subarachnoid 
space, and assuming that decreasing bupivacaine dose to 8mg 
associated with the same adjuvants in the same doses (clonidine 
75µg + morphine 100µg), time for motor block regression would 
be reduced by 20%. Using  type  error (0.05) and type b error (0.2) 
– a power of test of 80%, the number of cases calculated per group 
was 33. Therefore, an “n” of 66 subjects distributed into 2 groups 
was required to assess the differences existing between groups for 
the variable studied.
Sixty-six (66) subjects were randomly allocated to 2 
groups (GI and GII), using randomization software (SAS 9.1). Both 
the anesthesiologist performing the block and the anesthesiologist 
evaluating the parameters studied were blinded to the idenity of 
the spinal solution employed.                 
In both  groups, the LA used was  hyperbaric bupivacaine 
0.5% associated with adjuvant morphine and clonidine.  Two 
groups were formed, according to the dose of bupivacaine used: GI - 
bupivacaine 8.0mg (1.6mL) + clonidine 75µg (0.5mL) + morphine 
100µg (1.0mL) + saline 0.9% (0.9mL); GII-bupivacaine 10mg 
(2.0mL) + clonidine 75µg (0.5mL) + morphine 100µg (1.0mL) 
+ saline 0.9% (0.5mL). Saline 0.9% was added to the solution in 
both groups to obtain a total volume of 4mL. The drugs used were 
commercial products supplied by only one manufacturer, without 
determination of lot number. Solution densities were analyzed by 
the laboratory manufacturing the drugs, using digital density meter 
Anton Paar Model DMA 4500, previously calibrated with milli-Q 
water at 37ºC. The characteristics of the resulting solutions are 
found in Table 1.
TABLE 1 – Characteristics of anesthetic solutions.
 volume density at 37ºC bupivacaine clonidine morphine
 (mL) (g.mL-1) mg mg mg
Group  I 4 1.0107 8 75 100
Group  II 4 1.0125 10 75 100
The pregnant women were fasted and had not been given 
any preanesthetic medication. In the operating room, all were 
continuously monitored with cardioscope in DII lead, noninvasive 
arterial blood pressure monitor and pulse oximeter. After venous 
access with an 18G cannula, 500 to 750 mL of lactated Ringer’s 
solution was administered before the spinal block. Subarachnoid 
anesthesia was performed at the L3-L4 interspace with the patients 
in the sitting position. A Whitacre 27G or Quincke 25G needle 
was used, in case of a technically difficult spinal anesthesia. The 
anesthetic solution was injected at a rate of 1mL.15s-1, without 
barbotage. After performance of the spinal block, the pregnant 
women were placed in the supine position, and a Crawford wedge 
was used for left uterine displacement until birth. Supplemental 
oxygen was administered (2 to 3 L.min-1) with the aid of nasal 
prongs. Hydration was maintained with lactated Ringer solution 
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(10mL.kg-1.hour-1). The following parameters were studied: 1) 
onset of sensory block – time elapsed from the end of intrathecal 
injection of the anesthetic (evaluated each minute) to loss of 
painful pinprick sensation in T10; 2) maximum level of sensory 
block-evaluated 20 minutes after the end of anesthetic injection; 3) 
maximum level of motor block - evaluated 20 minutes after the end 
of anesthetic injection, according to a modified Bromage scale: 0 = 
free movement of the lower limbs (nil); 1 = able to flex knees and 
move feet; 2 = just able to flex feet; 3 = completely unable to move 
lower limbs; 4) time for motor block regression- time interval 
between end of anesthetic injection in the subarachnoid space and 
free movement of the lower limbs (0 – nil); 5) discomfort in the 
intraoperative period – complaint of pain (VNS ≥ 3) requiring 
the intravenous use of opioid (fentanyl 100µg) associated with 
midazolam (1 to 2 mg);  6) total duration of analgesia – time 
interval between the end of solution injection in the subarachnoid 
space and spontaneous complaint of pain (VNS≥ 3) reported by 
the patient during stay in the postanesthetic care unit (PACU). The 
use of tenoxicam (40mg) and dipyrone (30 mg.kg-1) was adopted, 
only after the first spontaneous complaint of pain (VNS ≥ 3), 
while in the PACU; 7) maternal  cardiovascular and respiratory 
parameters: mean arterial pressure (PAM - mmHg), heart rate (HR-
beats per minute), respiratory rate (breaths per minute) and oxygen 
saturation (SpO2 - %), were assessed in the following time points: 
before the block (M0); immediately after the block (M1);  every 
five minutes during surgery (M2); and at the end of surgery (M3); 
8) level of consciousness in the intraoperative period, according to 
a scale proposed by Filos et al.10  and  modified by Braz et al.11: 1= 
awake (anxious, agitated); 2= awake (calm); 3=drowsy; 4=asleep 
(awakes with verbal stimulation); 9) intraoperative maternal 
side-effects: nausea, vomiting, pruritus, respiratory depression 
(SpO2 ≤ 90% and respiratory rate below 10 rpm); 10) neonatal 
repercussions: through the Apgar score at one and five minutes.
Arterial hypotension was defined as a mean arterial 
blood pressure less than 70 mmHg. If present, hypotension was 
treated with a rapid infusion of crystalloid solution. If persistent, it 
was treated with ephedrine (5mg – venous bolus); bradycardia was 
defined as a decrease in heart rate for values below 50 beats per 
minute and it was treated with atropine (10-20µg.kg-1). In anxious 
and agitated patients, use of venous midazolam (1.0 to 5.0 mg) 
was recommended.
Fetal extraction time was defined as the interval from skin 
incision to placental delivery. The duration of surgery (minutes) 
was defined as the interval from skin incision to the end of surgery.
Statistical analysis
For statistical analysis of patient characteristics, the 
ANOVA test was used. To study the onset of sensory block, 
duration of analgesia, and time for motor block regression, the 
Student’s t test was used; for degree of motor block, level of 
sensory block, ephedrine requirement, maternal side-effects and 
level of consciousness; incidence of hypotension, the chi-square 
test was used; for intraoperative discomfort, Fisher’s exact test 
was used. On statistical analysis of cardiovascular and respiratory 
parameters, M2 was the time point considered the average of the 
mean values obtained in 5-minute intervals during surgery and the 
MANOVA test was used. The level of significance was set at 5%. 
Results
Anthropometric data analysis showed a significance 
difference between the groups, regarding height and body mass 
index (Table 2).  The mean time and standard deviation for surgery 
duration (minutes) and fetal extraction (minutes) were: 75.48 ± 
13.29 and 17.48 ± 5.50, in GI and 74.75 ± 14.69 and 16.15 ± 5.58 
in GII, respectively. There was no significant difference between 
the groups (p=0.44). 
TABLE 2 – Anthropometric data.
 Group I (n = 33)
Group II 
(n = 33) p
Age (years)* 31.91 ±  6.35 29.27 ± 6.25 0.23
Weight (Kg)* 81.00 ± 11.90 79.34 ± 11.52 0.54
Height (m)* 1.59 ± 0.05 1.62 ± 0.06 0.024
BMI (kg.m -2)* 32.00 ± 4.05 30.20 ± 3.62 0.027
Values expressed in Mean ± SD
*Student’s t test
The onset of sensory block was similar between groups 
(p=0.43). For maximum level of sensory block, there was a 
predominance of T4 level in more than 70% of cases, without any 
significant difference between groups. In both groups, the majority 
of patients had level 3 motor block and the time for motor block 
regression was significantly longer (p= 0.00073) in GII. In the 
intraoperative period, a mean time of 65.00 ± 10.00 minutes, the 
number of patients reporting pain (VNS≥ 3) was similar in both 
groups (p= 0.11). In GI, four patients required fentanyl (100µg) 
and midazolam (2.0mg) intravenously. Both groups showed 
similarities in the total duration of analgesia and number of 
patients reporting pain (VNS≥ 3) in the immediate postoperative 
period (PAC). Data relative to block characteristics are found in 
Table 3. 
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TABLE 3 – Block characteristics.
 Group I Group  II p
Onset of sensory 
block (min)* 3.88 ± 1.32 3.93 ± 1.63 0.43
Maximum level of 
sensory block**
T2 05 (15.1%) 02 (6%) 0.25
T4 24 (72.7%) 27 (81.8%) 0.77
T6 06 (18.1%) 04 (12.1%) 0.36
Total duration of 
analgesia (min) * 163.66 ± 25.67 191.18 ± 41.99 0.38
n 12 (36.36%) 11 (33.33%) 0.25
Degree of motor 
block**
2 01 (3%) 01 (3%)
3 32 (96.9%) 32 (96.9%)
Time for motor 
block regression*
198.48 ± 47.63 232.84 ± 63.66 0.00073
Values expressed in Mean ±SD; number (n) and percentage of patients (%)
*Student’s t test
**Chi-square test
Hemodynamic repercussions were similar between 
the groups. A comparison of mean MAP and HR values, in the 
different time periods studied, did not show any significant 
difference between groups (p > 0.05).  Individual analysis of 
cardiovascular parameters indicated arterial hypotension (MAP 
< 70 mmHg) in M2 (intraoperative period– 15 minutes), in nine 
and 16 patients from groups I and II, respectively, without any 
significant difference (p= 0.055) and in 22 patients from GI and in 
20 from GII, in M2 – 60 min, without any significant difference 
(p = 0.07). The number of patients requiring ephedrine totaled 14 
and 18 in groups I and II, respectively, without any significant 
difference (p= 0.97). The mean dose of ephedrine used in both 
groups I and II was 13.9 mg and 9.5 mg, respectively, without any 
significant difference (p= 0.06).
In both groups, individual analysis showed a decrease 
in HR (< 50 bpm) in seven patients, with four in Group I and 
three in Group II. This event occurred in the PACU, and the use of 
intravenous atropine was necessary (0.5 mg). 
All patients maintained respiratory rate above 10 breaths 
per minute and peripheral O2 saturation between 95 and 100%. In 
both groups, the Apgar score ranged from 8 to 10 and 9 to 10 at 
one and five minutes, respectively. 
Concerning the level of consciousness (Table 4), a 
predominance of drowsy or sleeping patients was observed in both 
groups. In group I, two patients were anxious (score 1).
TABLE 4 – Level of consciousness.
Group I Group II
Anxious 02 (6%) 0 (0%)







Values expressed in number and percentage of patients (%)
The incidence of maternal side-effects is shown in Table 
5 and occurred in a similar manner between groups. Nausea and 
vomiting were observed especially in the presence of arterial 
hypotension and at the time of the revision of the abdominal cavity. 
Pruritus was reported in the intraoperative and postoperative 
periods (PARU).
TABLE 5 – Adverse effects.
Group I Group II
Nausea 10 (30.3%) 11 (33.3%)
Vomiting 04 (12.1%) 05 (15.11%)
Pruritus 24 (72.7%) 28 (84.8%)
Values expressed in number and percentage of patients (%)
Discussion
Most cesarean sections are performed under spinal 
anesthesia, involving the association between local anesthetics 
and subarachnoid adjuvants such as opioids and alpha2-agonists. 
The reason to combine drugs is because the use of low doses (7.5 
to 10mg) of spinal hyperbaric bupivacaine alone has been shown 
to be insufficient to produce adequate perioperative analgesia. The 
incidence of pain is reported to be around 71%1. A higher incidence 
of arterial hypotension (50 a 85%) has been described with the 
use of higher doses (12 to 15mg)2,12-14 of hyperbaric bupivacaine. 
In addition to high doses of local anesthetics, other factors may 
contribute to a higher incidence of arterial hypotension15-18, such 
as oxytocin infusion and factors involved in the cephalic spread of 
local anesthetics in the cerebrospinal fluid. 
The slow onset of action of morphine can explain the low 
efficacy in the quality of surgical analgesia and also contributes 
to the delayed appearance of adverse effects, such as respiratory 
depression, pruritus, urinary retention, postoperative nausea and 
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vomiting.  The incidence of these effects is minimized by the use 
of low spinal doses of morphine (100mg), as recommended for 
cesarean section and used in this study, without compromising the 
quality of postoperative analgesia2,19-25.
Another class of drugs highlighted as adjuvants in 
spinal anesthesia includes the α2-adrenergic agonists. Its main 
representative is clonidine which interacts with local anesthetics, 
increasing potassium conductance in isolated neurons. This action 
intensifies and prolongs the conduction block of local anesthetics. 
It indirectly reduces the absorption of local anesthetics by a 
vasoconstrictor effect, mediated by α2 postsynaptic receptors, 
improving the quality and increasing the duration of the anesthetic 
block. Its mechanism of antinociception is due to action on α2-
adrenoceptors in the dorsal horn of the spinal cord. This effect 
seems to be more intense during pregnancy4,5,7,8,22,26-28.
Although the literature reports clonidine doses ranging 
from 15 to 150µg, in conjunction with local anesthetics and opioids 
for subarachnoid use in cesarean section, there is still no consensus 
on the best dose to use in this type of procedure. Recently, a dose 
of 1.0µg/kg of clonidine combined with bupivacaine has been 
recommended. However, good results have been obtained with 
doses of 150µg. Higher doses should be avoided because of greater 
hemodynamic repercussions4,8,16,26,27,29.
Owing to its sympatholytic action in the CNS and 
peripheral nerve endings, clonidine can produce hypotension 
and bradycardia, mainly manifested more than 30 minutes after 
intrathecal injection22,30. In this study, hemodynamic alterations 
occurred mainly in the intraoperative period in both groups. 
However, these changes were not significant and occurred after 
birth. The number of patients presenting with arterial hypotension 
and requiring ephedrine in the intraoperative period was higher 
in group II, a fact attributed to the higher dose of bupivacaine 
used, since the doses of the adjuvant agents were the same and 
the maximum level of sensory  block was similar in both groups.
Similar to our results, Lavand’homme et al.8 using 
different doses of bupivacaine (9 to 11mg) associated with 
two doses of clonidine (75 and 150 µg), also did not observe 
significant alterations in arterial blood pressure in the first 30 
minutes. However, with a dose of 150 µg, those authors reported 
significant alterations in arterial blood pressure, 30 minutes 
after administration. In another study26, using bupivacaine doses 
equivalent to those employed in this study (8.0 and 10mg) 
associated with 50µg of clonidine, arterial hypotension was 
observed at 25 minutes after the performance of the block in 35% 
and 57% dos patients, respectively, and the authors concluded that 
this was a dose-dependent effect of bupivacaine.  
Regarding heart rate, the mean heart rate values decreased 
30 minutes after the block, without bradycardia (HR ≤ 50 bpm). 
However, individual analysis showed that 45 minutes after the 
block the use of atropine was required in 12% and 9% of patients 
in groups I and II, respectively. These findings are similar to those 
found by Lavand’homme et al.8, who observed bradycardia in 7% 
and 13% of the patients 30 minutes after the use of two different 
doses of clonidine, 75µg and 150µg, respectively, justifying the 
dose-dependent bradycardic effect of clonidine. 
The adverse effects on the product of conception, due 
to hemodynamic repercussions, were controlled by left uterine 
displacement, volume expansion and ephedrine. Therefore, 
newborns did not show any signs of fetal distress, with results 
similar to those described in the literature confirming the safety of 
drug combination used2,22,28.
The total duration of analgesia was similar in both 
groups, observing that 36% and 33% of patients in groups I and 
II reported pain after the block in the postanesthesia care unit at 
163 and 191 minutes, respectively. Dipyrone and tenoxicam were 
used for pain control. Other authors7 evaluating the analgesic 
efficacy of the combined use of hyperbaric bupivacaine (12.5 mg) 
and morphine 100µg and two doses of clonidine (15 and 30 µg) 
in cesarean section, reported the absence of intraoperative pain 
and a mean  time period of analgesia of 712 and 902 minutes, 
respectively, with the two different doses of clonidine.
Other studies have shown that the analgesic effect 
of intrathecal clonidine (50 to 150µg) associated with 0.5% 
hyperbaric bupivacaine (8.0 to 11mg), without morphine, and with 
or without a lipid soluble opioid, usually does not last longer than 
246 minutes8,26,27.
In our study, pain in the intraoperative period was 
reported by four patients in the group receiving the lower dose of 
bupivacaine and occurred in a mean time period of 65 minutes. 
These findings are in agreement with those reported by Kothari 
et al.26 who used the same doses of bupivacaine employed in this 
study, associated with only 50µg of clonidine, and also observed 
discomfort in 4.28% of patients from the group receiving 8mg of 
bupivacaine in the intraoperative period.
Concerning time for motor block regression, it was 
significantly longer in the group using 10 mg of bupivacaine. 
Although data in the literature4,27,28 confirm that clonidine 
potentiates the motor block produced by local anesthetics, the 
difference found between both groups may be attributed to a higher 
dose of bupivacaine used in group II, since the dose of clonidine 
was the same in all patients studied. 
Due to the activation of α2-adrenergic receptors in the 
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Central Nervous System (CNS), clonidine causes a reduction in 
the release of norepinephrine from the Locus Coeruleus and an 
increase in the activity of inhibitory interneurons (GABA), with 
consequent sedation, anxiolytic action and hypnosis. This dose-
dependent effect occurs 20 to 30 minutes after administration5,7. 
Systemic administration of high doses of morphine can also alter 
the level of consciousness, an effect attributed to its action on K 
(kappa) receptors in the CNS.2 Similarly to other studies8,22,26,28 
that have described an important sedative effect of clonidine, we 
observed that more than 75% of patients in both groups, were 
drowsy and asleep, 30 minutes after performance of the block. 
Pruritus, attributed to morphine, was the most common 
side effect found in this research study. It occurred in 72% and 84% 
in groups I and II, respectively, results similar to those described 
in the literature where 85% of pruritus is reported 45 minutes after 
the use of 100µg subarachnoid morphine for cesarean section7,19.
Conclusion
Morphine and clonidine to low doses of hyperbaric 
bupivacaine produced adequate anesthesia for cesarean section 
and good postoperative analgesia, without any maternal and fetal 
repercussions.
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